{"database": "lobbying", "table": "lobbying_activities", "rows": [[2377238, "9471a208-f8d9-4de4-a1ef-51632a0c0bed", "Q4", "LUPIN PHARMACEUTICALS INC", 401104766, "LUPIN PHARMACEUTICALS INC", 2019, "fourth_quarter", "MMM", "The additional CPI penalty on generic drugs within Medicaid.", "HOUSE OF REPRESENTATIVES,SENATE,U.S. Agency for International Development (USAID),U.S. Trade Representative (USTR)", null, 109158, 0, 0, "2020-01-02T16:28:39.110000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2377238"], "units": {}, "query_ms": 0.4730320069938898, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}